NorthSea Therapeutics develops therapeutics for NASH and other metabolic, inflammatory and fibrotic diseases.
Total raised: $149.59M
Investors 5
Date | Name | Website |
- | BioGenerat... | biogenerat... |
- | Forbion | forbion.co... |
- | Ysios Capi... | ysioscapit... |
- | Sofinnova ... | sofinnova.... |
- | New Scienc... | newscience... |
Funding Rounds 3
Date | Series | Amount | Investors |
17.12.2021 | Series C | $80M | - |
08.01.2020 | Series B | $40M | - |
13.12.2017 | Series A | $29.59M | New Scienc... |
Mentions in press and media 17
Date | Title | Description | Source |
21.02.2024 | NorthSea Therapeutics Initiates Phase 2A Trial of Orziloben ... | • Phase 2a study evaluating the safety, tolerability, PK, and PD of Orziloben in IFALD • The study w... | forbion.co... |
29.12.2021 | These are the 21 biggest funding rounds of 2021 in the Nethe... | Over the last decade, the startup ecosystem’s value in the Netherlands has been rising fast. With a ... | siliconcan... |
28.12.2021 | Top milestone of Amsterdam 2021: Startups that hit the headl... | Amsterdam as a startup ecosystem packs an increasingly big punch. Over the last decade, the overall ... | siliconcan... |
21.12.2021 | Amsterdam-based NorthSea Therapeutics secures €70.84M to dev... | Amsterdam-based NorthSea Therapeutics (NST), a clinical-stage biotech company developing first-in cl... | siliconcan... |
17.12.2021 | NorthSea Therapeutics Completes US$80 Million Series C Fundr... | NorthSea Therapeutics B.V., (‘NST’) a biotech company developing novel and innovative strategies for... | marketscre... |
17.12.2021 | Ysios Capital lidera una inversión de $80M en Northsea Thera... | 17/12/2021 Nota de prensa YSIOS CAPITAL LIDERA UNA INVERSIÓN DE $80 MILLONES EN NORTHSEA THERAPEUT... | webcapital... |
17.12.2021 | NorthSea Therapeutics Completes $80 Million Series C Fundrai... | - | sofinnova.... |
17.12.2021 | NorthSea Therapeutics B.V. announced that it has received $8... | NorthSea Therapeutics B.V. announced that it has raised $80 million in a round of funding co-led by ... | marketscre... |
17.12.2021 | NorthSea Therapeutics Completes US$80 Million Series C Fundr... | Amsterdam, The Netherlands, 17 December 2021 – NorthSea Therapeutics B.V., (‘NST’) a biotech company... | forbion.co... |
08.01.2020 | NorthSea raises $40M to wrap up phase 2b NASH trial | NorthSea Therapeutics has raised a $40 million (€36 million) series B round to wrap up its phase 2b ... | fiercebiot... |
Show more